ABT-863solid tumorsCRObreastlung cancersIACUC
…usted CD8+ T cells and enhanced anti-tumor immunity.Conclusions ABT-863 is a first-in-class CCR8 inverse agonist antibody that promotes…
1articles mentioning drugs
10drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: ABT-863 ×
ABT-863
This drug is selected. Its supporting articles are shown below.